4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-24-004310
President and CEO acquired 685,131 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gillheeney Gary S. President and CEO | 2024-02-21 | Grant or award | +685,131 | 2,362,062 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gillheeney Gary S. President and CEO | 2024-02-21 | Grant or award · Stock Option (Right to Buy) | +1,238,729 | 1,238,729 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…